An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue
Open Access
- 15 August 2004
- journal article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 18 (16) , 1976-1980
- https://doi.org/10.1101/gad.1216504
Abstract
The c-Jun NH2-terminal kinase (JNK) is activated during obesity. One consequence of obesity is that JNK phosphorylates the adapter protein insulin receptor substrate 1 (IRS-1) on Ser 307 and inhibits signaling by the insulin receptor. JNK can therefore cause peripheral insulin resistance during obesity and may contribute to the development of type 2 diabetes. Here we report that the JNK-interacting protein 1 (JIP1) scaffold protein, which binds components of the JNK signaling module, is essential for JNK activation in the adipose tissue of obese mice. These data identify JIP1 as a novel molecular target for therapeutic intervention in the development of obesity.Keywords
This publication has 27 references indexed in Scilit:
- Adiponectin and Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Regulation of MAP Kinase Signaling Modules by Scaffold Proteins in MammalsAnnual Review of Cell and Developmental Biology, 2003
- Repression of phospho‐JNK and infarct volume in ischemic brain of JIP1‐deficient miceJournal of Neuroscience Research, 2003
- JNK: a new therapeutic target for diabetesCurrent Opinion in Pharmacology, 2003
- c-Jun N-terminal Kinase (JNK) Mediates Feedback Inhibition of the Insulin Signaling CascadeJournal of Biological Chemistry, 2003
- A central role for JNK in obesity and insulin resistanceNature, 2002
- Requirement of the JIP1 scaffold protein for stress-induced JNK activationGenes & Development, 2001
- Islet-Brain1/JNK-interacting Protein-1 Is Required for Early Embryogenesis in MicePublished by Elsevier ,2001
- Loss of Insulin Signaling in Hepatocytes Leads to Severe Insulin Resistance and Progressive Hepatic DysfunctionMolecular Cell, 2000
- The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetesNature Genetics, 2000